Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Oct 24, 2026 | Capital Blue Cross | Transurethral Water Vapor Thermal Therapy and Transurethral Water Jet Ablation (Aquablation) for Benign Prostatic HypertrophyPayerPolicy · CAPBLUE-MP-4.053 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Transmyocardial RevascularizationPayerPolicy · CAPBLUE-MP-1.057 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Total Artificial Hearts and Implantable Ventricular Assist DevicesPayerPolicy · CAPBLUE-MP-1.026 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Threshold Electrical Stimulation as a Treatment of Motor DisordersPayerPolicy · CAPBLUE-MP-6.046 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic HyperplasiaPayerPolicy · CAPBLUE-MP-1.164 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Sympathetic Therapy for the Treatment of PainPayerPolicy · CAPBLUE-MP-6.045 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Surgical Ventricular RestorationPayerPolicy · CAPBLUE-MP-1.082 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Surgical Treatments for Breast Cancer Related LymphedemaPayerPolicy · CAPBLUE-MP-1.161 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Surgical Treatment of Sleep Apnea and SnoringPayerPolicy · CAPBLUE-MP-1.128 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Surgical Treatment of GynecomastiaPayerPolicy · CAPBLUE-MP-1.129 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Surgery for Groin Pain in AthletesPayerPolicy · CAPBLUE-MP-1.163 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Substance Use Disorder Site of ServicePayerPolicy · CAPBLUE-MP-4.052 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Subcutaneous Hormone Pellet ImplantsPayerPolicy · CAPBLUE-MP-2.345 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Step Therapy Treatment of Stage Four, Advanced Metastatic Cancer and Severe Related Health ConditionsPayerPolicy · CAPBLUE-MP-2.373 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Stem Cell Therapy for Peripheral Arterial DiseasePayerPolicy · CAPBLUE-MP-2.089 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Somatic Genetic Testing to Select Individuals with Melanoma or Glioma for Targeted Therapy or ImmunotherapyPayerPolicy · CAPBLUE-MP-2.364 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment of Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, NTRK, and HER2)PayerPolicy · CAPBLUE-MP-2.316 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Somatic Biomarker Testing For Immune Checkpoint Inhibitor Therapy (MSIMMR, PD-L1, TMB)PayerPolicy · CAPBLUE-MP-2.388 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Therapy in Non-Small Cell LungPayerPolicy · CAPBLUE-MP-2.241 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Serum Biomarkers for Human Epididymis Protein 4 (HE4)PayerPolicy · CAPBLUE-MP-2.269 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Serum Antibody Markers for Diagnosing Inflammatory Bowel DiseasePayerPolicy · CAPBLUE-MP-2.222 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Sacral Nerve Neuromodulation-StimulationPayerPolicy · CAPBLUE-MP-1.033 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Rhinomanometry and Acoustic/Optical RhinometryPayerPolicy · CAPBLUE-MP-2.088 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Renal Denervation for Uncontrolled HypertensionPayerPolicy · CAPBLUE-MP-1.166 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Reconstructive Breast Surgery Including Management of Breast Implants, External Breast Prosthesis and Post Mastectomy BrasPayerPolicy · CAPBLUE-MP-1.103 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Radiofrequency Ablation of Thyroid TumorsPayerPolicy · CAPBLUE-MP-1.165 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver TumorsPayerPolicy · CAPBLUE-MP-1.084 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung CancerPayerPolicy · CAPBLUE-MP-2.337 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Proteogenomic Testing for Patients With CancerPayerPolicy · CAPBLUE-MP-2.343 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Preimplantation Genetic TestingPayerPolicy · CAPBLUE-MP-7.009 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Plasma Exchange (PE)PayerPolicy · CAPBLUE-MP-4.031 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Placental/Umbilical Cord Blood as Source of Stem CellsPayerPolicy · CAPBLUE-MP-9.001 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Pharmacogenomic and Metabolite Markers for Patients Treated with ThiopurinesPayerPolicy · CAPBLUE-MP-2.218 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Percutaneous Electrical Nerve Stimulation (PENs) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · CAPBLUE-MP-6.050 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Paraspinal Surface Electromyography to Evaluate and Monitor Back PainPayerPolicy · CAPBLUE-MP-2.097 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Other Therapies of HyperhidrosisPayerPolicy · CAPBLUE-MP-2.005 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used with Autologous Bone Marrow)PayerPolicy · CAPBLUE-MP-2.080 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Orthognathic SurgeryPayerPolicy · CAPBLUE-MP-1.101 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)PayerPolicy · CAPBLUE-MP-2.083 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Oncological Applications of Photodynamic Therapy including Barrett's EsophagusPayerPolicy · CAPBLUE-MP-4.019 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Occipital Nerve StimulationPayerPolicy · CAPBLUE-MP-2.372 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Noninvasive Imaging for the Evaluation and Monitoring of Patients with Chronic Liver DiseasePayerPolicy · CAPBLUE-MP-2.252 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNAPayerPolicy · CAPBLUE-MP-2.261 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Non-Emergent Ground Transport ServicesPayerPolicy · CAPBLUE-MP-3.009 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Next-Generation Sequencing For The Assessment of Measurable Residual DiseasePayerPolicy · CAPBLUE-MP-2.379 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | NeurofeedbackPayerPolicy · CAPBLUE-MP-2.029 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Neural TherapyPayerPolicy · CAPBLUE-MP-8.012 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · CAPBLUE-MP-4.004 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Multimarker Serum Testing Related to Ovarian CancerPayerPolicy · CAPBLUE-MP-2.270 | Metadata changed |
|---|
| Oct 24, 2026 | Capital Blue Cross | Multicancer Early Detection TestingPayerPolicy · CAPBLUE-MP-2.387 | Metadata changed |
|---|